New Delhi, Sept. 29 -- IN THE SPACE of less than a decade, medicine acquired a means of doing what millennia of diets and exhortation could not. A new class of drugs, GLP-1 receptor agonists, can strip a fifth or more from a patient's body weight. This week Britain became the second large market, after America, to make one such treatment, Novo Nordisk's Wegovy, available in tablet form as an alternative to injecting it.

Published by HT Digital Content Services with permission from MINT....